Syros Pharmaceuticals, Inc. · OTC:SYRS
Samsara BioCapital, L.P. reported a 2.60% stake in Syros Pharmaceuticals, Inc. (Schedule 13D/A)
Event Nov 18, 2024 · Filed Mar 27, 2025
Samsara BioCapital, L.P. reported a 2.60% stake in Syros Pharmaceuticals, Inc., 707,114 shares, with active intent on Nov 18, 2024. Filed Mar 27, 2025 (Schedule 13D/A).
- Stake
- 2.60%
- Shares
- 707,114
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 2.60% | 707,114 |
| Samsara BioCapital GP, LLC | 2.60% | 707,114 |
| Srinivas Akkaraju | 2.60% | 707,114 |